108 related articles for article (PubMed ID: 3016088)
1. Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.
Anderson PW; Pichichero ME; Insel RA; Betts R; Eby R; Smith DH
J Immunol; 1986 Aug; 137(4):1181-6. PubMed ID: 3016088
[TBL] [Abstract][Full Text] [Related]
2. Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197.
Anderson PW; Pichichero ME; Stein EC; Porcelli S; Betts RF; Connuck DM; Korones D; Insel RA; Zahradnik JM; Eby R
J Immunol; 1989 Apr; 142(7):2464-8. PubMed ID: 2784464
[TBL] [Abstract][Full Text] [Related]
3. Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197.
Anderson P; Pichichero ME; Insel RA
J Clin Invest; 1985 Jul; 76(1):52-9. PubMed ID: 3874882
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
[TBL] [Abstract][Full Text] [Related]
5. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen.
Bewley KM; Schwab JG; Ballanco GA; Daum RS
Pediatrics; 1996 Nov; 98(5):898-904. PubMed ID: 8909483
[TBL] [Abstract][Full Text] [Related]
6. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
[TBL] [Abstract][Full Text] [Related]
7. The intrinsic affinity constant (K) of anticapsular antibody to oligosaccharides of Haemophilus influenzae type b.
Hetherington SV
J Immunol; 1988 Jun; 140(11):3966-70. PubMed ID: 3259602
[TBL] [Abstract][Full Text] [Related]
8. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine.
Anderson P; Pichichero M; Edwards K; Porch CR; Insel R
J Pediatr; 1987 Nov; 111(5):644-50. PubMed ID: 3499499
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide.
Lucas AH; Azmi FH; Mink CM; Granoff DM
J Immunol; 1993 Mar; 150(5):2056-61. PubMed ID: 8436834
[TBL] [Abstract][Full Text] [Related]
11. [Tolerance and immunogenicity of the capsular polyoside vaccine against Haemophilus influenzae type b. A study of 325 children 15 to 71 months of age].
Reinert P; Postel-Vinay A; Bessa E; Hessel L; Schulz D; Cadoz M
Ann Pediatr (Paris); 1989 Jan; 36(1):20-5. PubMed ID: 2784652
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
[TBL] [Abstract][Full Text] [Related]
14. Haemophilus influenzae type b immunization of children with sickle cell diseases.
Frank AL; Labotka RJ; Rao S; Frisone LR; McVerry PH; Samuelson JS; Maurer H; Yogev R
Pediatrics; 1988 Oct; 82(4):571-5. PubMed ID: 3262857
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine formulation in healthy adults.
Bulkow LR; McMahon BJ; Wainwright RB; Parkinson AJ; Wainwright KY; House J
Arctic Med Res; 1993 Jul; 52(3):118-26. PubMed ID: 8397580
[TBL] [Abstract][Full Text] [Related]
16. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
Gordon LK
Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
Käyhty H; Peltola H; Eskola J
Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853
[TBL] [Abstract][Full Text] [Related]
19. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
20. Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines.
Schneerson R; Robbins JB; Barrera O; Sutton A; Habig WB; Hardegree MC; Chaimovich J
Prog Clin Biol Res; 1980; 47():77-94. PubMed ID: 6970933
[No Abstract] [Full Text] [Related]
[Next] [New Search]